1. Home
  2. BLLN vs AXTI Comparison

BLLN vs AXTI Comparison

Compare BLLN & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$93.23

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo AXT Inc

AXTI

AXT Inc

SELL

Current Price

$62.00

Market Cap

4.2B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
BLLN
AXTI
Founded
2016
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.2B
IPO Year
2025
1998

Fundamental Metrics

Financial Performance
Metric
BLLN
AXTI
Price
$93.23
$62.00
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
★ $129.00
$91.60
AVG Volume (30 Days)
561.3K
★ 5.9M
Earning Date
08-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 103.40
N/A
EPS
★ 0.48
0.16
Revenue
★ $305,112,000.00
$99,361,000.00
Revenue This Year
$49.05
$146.79
Revenue Next Year
$26.16
$111.35
P/E Ratio
★ $204.98
$428.16
Revenue Growth
★ 99.97
31.09
52 Week Low
$61.96
$4.35
52 Week High
$150.44
$143.16

Technical Indicators

Market Signals
Indicator
BLLN
AXTI
Relative Strength Index (RSI) 38.68 40.09
Support Level $88.85 $53.06
Resistance Level $98.14 $72.71
Average True Range (ATR) 7.14 5.41
MACD -2.29 -1.83
Stochastic Oscillator 6.44 1.64

Price Performance

Historical Comparison
BLLN
AXTI

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

Share on Social Networks: